Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-31 Sale | 2024-11-04 4:34 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 810 | $15.79 | $12,792 | 110,093 (Direct) | View |
| 2024-11-01 Sale | 2024-11-04 4:34 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 598 | $15.94 | $9,531 | 161,236 (Direct) | View |
| 2024-11-01 Sale | 2024-11-04 4:32 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 160 | $15.88 | $2,540 | 3,503 (Direct) | View |
| 2024-08-02 Sale | 2024-08-05 4:25 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 688 | $20.14 | $13,857 | 219,179 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:43 pm | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 964 | $23.89 | $23,033 | 176,079 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:42 pm | NovoCure Ltd | NVCR | Scannell Timothy J Director | 964 | $23.89 | $23,027 | 14,210 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:42 pm | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 964 | $23.89 | $23,025 | 89,421 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 4:09 pm | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 3,324 | $16.02 | $53,253 | 251,235 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 4:08 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 2,519 | $16.02 | $40,358 | 160,098 (Direct) | View |
| 2024-02-28 Sale | 2024-02-29 4:38 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 2,078 | $16.14 | $33,545 | 318,965 (Direct) | View |
| 2024-02-28 Sale | 2024-02-29 4:28 pm | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 2,303 | $16.14 | $37,177 | 326,479 (Direct) | View |
| 2023-11-07 Sale | 2023-11-08 4:22 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 382 | $12.65 | $4,832 | 124,511 (Direct) | View |
| 2023-09-01 Sale | 2023-09-05 4:24 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 883 | $21.82 | $19,265 | 99,650 (Direct) | View |
| 2023-09-01 Sale | 2023-09-05 4:24 pm | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 294 | $21.82 | $6,414 | 209,825 (Direct) | View |
| 2023-09-01 Sale | 2023-09-05 4:23 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 273 | $21.82 | $5,956 | 124,893 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-09 6:21 pm | N/A N/A | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 0 | $0 | 134,850 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:22 pm | N/A N/A | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 930 | $12.24 | 118,052 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:21 pm | N/A N/A | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 1,055 | $12.24 | 252,290 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 1,239 | $12.24 | 15,228 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,286 | $12.24 | 220,465 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 1,736 | $12.24 | 161,834 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:16 pm | N/A N/A | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,736 | $12.24 | 110,903 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-07 4:06 pm | N/A 2027-02-21 | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 124,373 | $22.82 | 470,608 (Indirect) | View |
| 2024-06-05 Option Award | 2024-06-06 6:37 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Ocean Allyson J Director | 10,282 | $0 | 10,282 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 6:13 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Madden Martin J. Director | 10,282 | $0 | 25,902 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:55 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Hung David Director | 10,282 | $0 | 19,423 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:43 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Stafford Kristin Director | 10,282 | $0 | 10,282 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:43 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 10,282 | $0 | 176,079 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:42 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Scannell Timothy J Director | 10,282 | $0 | 14,210 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:42 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 10,282 | $0 | 89,421 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:09 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 10,282 | $0 | 12,819 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:43 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 258,597 | $16.3 | 376,215 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:38 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 258,597 | $16.3 | 318,965 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:36 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 181,017 | $16.3 | 218,610 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:35 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 206,877 | $16.3 | 296,226 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:33 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer | 129,298 | $16.3 | 129,298 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:33 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Giladi Moshe Chief Science Officer | 129,298 | $16.3 | 147,945 (Direct) | View |
| 2023-12-31 Option Award | 2024-02-29 4:30 pm | N/A N/A | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 128 | $12.69 | 242,200 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:30 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 206,877 | $16.3 | 242,200 (Direct) | View |
| 2023-12-31 Option Award | 2024-02-29 4:28 pm | N/A N/A | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 3 | $12.69 | 326,479 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:28 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 118,954 | $16.3 | 326,479 (Direct) | View |
Ownership | 2024-01-12 4:57 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 0 | $0 | 227,173 (Direct) | View |
Ownership | 2023-12-20 4:23 pm | N/A N/A | NovoCure Ltd | NVCR | Giladi Moshe Chief Science Officer | 0 | $0 | 61,032 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-03 4:08 pm | N/A N/A | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 37,593 | $0 | 95,197 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-03 4:08 pm | 2024-10-31 2033-10-30 | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 57,604 | $13.3 | 95,197 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 7,752 | $7.15 | 117,793 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 7,736 | $11.46 | 117,793 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 2,480 | $11.44 | 117,793 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A 2026-02-24 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 17,968 | $0 | 117,793 (Direct) | View |